Brian Markison
2017
In 2017, Brian Markison earned a total compensation of $1.2M as President and Chief Executive Officer at RVL Pharmaceuticals plc.
Compensation breakdown
| Non-Equity Incentive Plan | $613,562 |
|---|---|
| Salary | $613,085 |
| Other | $135 |
| Total | $1,226,782 |
Markison received $613.6K in non-equity incentive plan, accounting for 50% of the total pay in 2017.
Markison also received $613.1K in salary and $135 in other compensation.
Rankings
In 2017, Brian Markison's compensation ranked 7,994th out of 14,666 executives tracked by ExecPay. In other words, Markison earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,994 out of 14,666 | 46th |
Division Manufacturing | 3,002 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 982 out of 2,075 | 53rd |
Industry group Drugs | 767 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 604 out of 1,333 | 55th |
Source: SEC filing on April 26, 2019.
Markison's colleagues
We found one more compensation record of an executive who worked with Brian Markison at RVL Pharmaceuticals plc in 2017.
2017
Tina deVries
RVL Pharmaceuticals plc
EVP, Research & Development
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019